GlobeNewswire 10.05.2019 Roche to present new data highlighting comprehensive approach to cancer care at 2019 American Societ...
GlobeNewswire 08.05.2019 Roche to present new OCREVUS (ocrelizumab) data analyses showing significant reduction of disability...
GlobeNewswire 07.05.2019 Roche presents data from the risdiplam pivotal FIREFISH and SUNFISH studies in spinal muscular atrop...
GlobeNewswire 06.05.2019 FDA approves Roche's Kadcyla for adjuvant treatment of people with HER2-positive early breast cancer...
GlobeNewswire 29.04.2019 New Roche data at the 2019 AAN Annual Meeting showcase breadth and promise of neuroscience portfolio
GlobeNewswire 26.04.2019 Roche and Spark Therapeutics, Inc. announce withdrawal and refiling of Premerger Notification and Re...
GlobeNewswire 23.04.2019 Roche launches new VENTANA HER2 Dual ISH companion diagnostic test for breast and gastric cancer pat...
GlobeNewswire 17.04.2019 Roche reports a strong start in 2019 and raises the outlook for the full-year
GlobeNewswire 03.04.2019 Roche and Spark Therapeutics, Inc. announce withdrawal and refiling of Premerger Notification and Re...
GlobeNewswire 01.04.2019 Roche's ipatasertib in combination with Tecentriq and chemotherapy shows promising anti-tumour activ...
GlobeNewswire 28.03.2019 Liquid Biopsy Research Tools, Services and Diagnostics: Global Market Analysis & Outlook Through 201...
GlobeNewswire 20.03.2019 Biopharmaceuticals Market Analysis & Outlook, 2019 to 2024 - Their Ability to Treat Previously Untre...
GlobeNewswire 19.03.2019 FDA approves Roche's Tecentriq in combination with chemotherapy for the initial treatment of adults ...
GlobeNewswire 15.03.2019 European Commission approves Roche's MabThera (rituximab) for a rare autoimmune disease
GlobeNewswire 14.03.2019 European Commission approves Roche's Hemlibra for people with severe haemophilia A without factor VI...
GlobeNewswire 12.03.2019 SPARK THERAPEUTICS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
GlobeNewswire 11.03.2019 Roche's VENTANA PD-L1 (SP142) Assay approved as first companion diagnostic to identify triple-negati...
GlobeNewswire 11.03.2019 FDA grants Roche's Tecentriq in combination with Abraxane accelerated approval for people with PD-L1...
GlobeNewswire 08.03.2019 European Commission approves Roche's Tecentriq in combination with Avastin and chemotherapy for the ...
GlobeNewswire 07.03.2019 Roche commences tender offer for all shares of Spark Therapeutics, Inc. for US$ 114.50 per share in ...
GlobeNewswire 07.03.2019 Roche submits supplemental new drug application to FDA for Venclexta plus Gazyva for previously untr...
GlobeNewswire 05.03.2019 Roche Annual General Meeting 2019
GlobeNewswire 28.02.2019 FDA approves Herceptin Hylecta for subcutaneous injection in certain HER2-positive breast cancers
GlobeNewswire 26.02.2019 Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Spark Therapeutics, Inc. (ONC...
GlobeNewswire 25.02.2019 Injection Pen Market - Global Industry Analysis, Trends, Market Size, and Forecasts up to 2024